Other speakers included Teresa López-Fando Salinas of the Asociación Española Contra el Cáncer giving the patients’ point of view; Ángel del Pozo of Biopraxis Research AIE from the industry side; researcher Álvaro Somoza of IMDEA Nanoscience; and VHIO’s Teresa Macarulla giving the clinicians’ point of view.
The latest innovations in nanomedicine for cancer were presented and discussed in front of an audience of more than 80 researchers, clinicians, students and industry professionals, as well as representatives from the World Health Organization (WHO) and journalists.
Germany, Austria, Belgium, France, Greece, Holland, Ireland, Iceland, Israel, Italy, Poland, Portugal, Spain, Switzerland, Turkey and United Kingdom are also holding events simultaneously on Nano World Cancer Day, each attended by nanomedicine experts from each country and from different backgrounds including researchers, physicians, oncologists and entrepreneurs.
Nano World Cancer Day was first held in 2013 and is organized at the European level by the European Technology Platform for Nanomedicine (ETPN) under European project ENATRANS (Enabling Nanomedicine Translation), and locally by the different components of the ETPN in each country.
